查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1660669

2025 年至 2033 年腫瘤分子診斷市場報告（按癌症類型、產品、技術、最終用戶和地區）

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球腫瘤分子診斷市場規模達到 48 億美元。癌症發生率的上升、分子診斷技術的不斷進步以及精準醫療的普及是推動市場成長的主要因素。

腫瘤分子診斷透過分析癌細胞的生物分子來識別癌細胞的存在。對血液、唾液和腫瘤組織樣本進行幾項測試，以檢測和測量 DNA、RNA 和細胞蛋白質中的特定基因序列。腫瘤分子診斷有助於快速分析並提供詳細資訊，進一步用於癌症的個人化治療。這些診斷解決方案可用於臨床和即時診斷（POC）測試以早期發現癌症。它們也用於血庫，以識別捐捐血液樣本中存在的病原體和傳染病。

由於生活方式的改變、老年人口的增加以及吸煙趨勢的增加而導致的癌症患病率上升是推動全球腫瘤分子診斷市場成長的主要因素之一。除此之外，對快速且準確診斷的需求不斷成長，以及下一代定序 (NGS) 技術的進步，也促進了市場的成長。此外，患有病毒和細菌感染的人數增加以及捐血活動的參與度不斷提高，對全球腫瘤分子診斷的需求產生了積極影響。然而，由於冠狀病毒病（COVID-19）的突然爆發，一些醫療機構正在採取措施減少就診次數，以減輕疫情對癌症患者的風險。此外，由於診斷資源被重新用於提供 COVID-19 檢測，從而導致腫瘤學檢測減少，癌症患者的定期篩檢也有所下降。

本報告解答的關鍵問題

  • 全球腫瘤分子診斷市場迄今表現如何？
  • COVID-19 對全球腫瘤分子診斷市場有何影響？
  • 主要的區域市場有哪些？
  • 根據癌症類型，市場分佈如何？
  • 根據產品，市場如何分類？
  • 基於科技的市場分化是怎樣的？
  • 根據最終用戶，市場分佈如何？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球腫瘤分子診斷市場的結構是怎樣的？
  • 產業的競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腫瘤分子診斷市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依癌症類型

  • 乳癌
    • 市場趨勢
    • 市場預測
  • 攝護腺癌
    • 市場趨勢
    • 市場預測
  • 大腸直腸癌
    • 市場趨勢
    • 市場預測
  • 子宮頸癌
    • 市場趨勢
    • 市場預測
  • 肝癌
    • 市場趨勢
    • 市場預測
  • 肺癌
    • 市場趨勢
    • 市場預測
  • 血癌
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：市場區隔：依產品

  • 儀器
    • 市場趨勢
    • 市場預測
  • 試劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依技術

  • 聚合酶鍊式反應（PCR）
    • 市場趨勢
    • 市場預測
  • 原位雜合技術
    • 市場趨勢
    • 市場預測
  • 晶片和微陣列
    • 市場趨勢
    • 市場預測
  • 等溫核酸擴增技術（INAAT）
    • 市場趨勢
    • 市場預測
  • 質譜分析
    • 市場趨勢
    • 市場預測
  • DNA 和 NGS 定序
    • 市場趨勢
    • 市場預測
  • 轉錄介導擴增 (TMA)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 參考實驗室
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場區隔：依國家
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bayer AG
    • Becton, Dickinson and Company
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Qiagen NV
    • Siemens Healthcare
    • Sysmex Corporation
Product Code: SR112025A2396

The global oncology molecular diagnostics market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.37% during 2025-2033. The rising prevalence of cancer, ongoing advancements in molecular diagnostic technologies, and increased adoption of precision medicine are primarily driving the market's growth.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

Breakup by Cancer Type:

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Others

Breakup by Product:

  • Instruments
  • Reagents
  • Others

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Chips and Microarrays
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • DNA and NGS Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Reference Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prostate Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Liver Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Lung Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Blood Cancer
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Polymerase Chain Reaction (PCR)
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In Situ Hybridization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chips and Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Mass Spectrometry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 DNA and NGS Sequencing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Transcription Mediated Amplification (TMA)
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton, Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Qiagen N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens Healthcare
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2024
  • Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
  • Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
  • Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Oncology Molecular Diagnostics Market Structure
  • Table 8: Global: Oncology Molecular Diagnostics Market: Key Players